Table 1 Characteristics of subjects according to treatment group
From: The effect of Astym® Therapy on muscle strength: a blinded, randomized, clinically controlled trial
Astym® (mean ± SD) | Placebo (mean ± SD) | Control (mean ± SD) | TOTAL (mean ± SD) | |
|---|---|---|---|---|
Age (years) | 42 ± 12 | 43 ± 13 | 35 ± 12 | 40 ± 13 |
Height (cm) | 166 ± 13 | 168 ± 12 | 170 ± 9 | 168 ± 11 |
Weight (kg) | 68 ± 11 | 70 ± 14 | 75 ± 20 | 71 ± 15 |
Functional score (0–80 points) | 60 ± 10 | 60 ± 9 | 60 ± 8 | 60 ± 9 |
Pre-treatment pain rating 0–10) | 2 ± 2 | 2 ± 2 | 3 ± 2 | 2 ± 2 |
Post-treatment Pain Rating (0–10) | 2 ± 2 | 3 ± 2 | 3 ± 2 | 3 ± 2 |
Gender (% Female) | 80 % | 67 % | 67 % | 71 % |
Lower extremity dominance (% Left) | 7 % | 13 % | 7 % | 9 % |
Involved side (% Left) | 40$ | 53 % | 47 % | 47 % |